欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SK/H/0289/001
药品名称Allopurinol Medreg 100 mg
活性成分
    • allopurinol 100.0 mg
剂型Tablet
上市许可持有人Medreg s.r.o. Na Florenci 2116/15 Nove Mesto, Prague 110 00 Czechia
参考成员国 - 产品名称Slovakia (SK)
Allopurinol Medreg 100 mg
互认成员国 - 产品名称
    • Poland (PL)
    • Romania (RO)
      Allopurinol Medreg 100 mg comprimate
    • Czechia (CZ)
      Allopurinol Medreg
许可日期2023/07/12
最近更新日期2023/07/25
药物ATC编码
    • M04AA01 allopurinol
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase